Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4448)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jan 24, 2022 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Popovic M, Matovina-Brko G, Jovic M, Popovic LS. Immunotherapy: A new standard in the treatment of metastatic clear cell renal cell carcinoma. World J Clin Oncol 2022; 13(1): 28-38 [PMID: 35116230 DOI: 10.5306/wjco.v13.i1.28] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v13/i1/28.htm |
| Number | Citing Articles |
| 1 |
Dilruba Sofia, Qilu Zhou, Leili Shahriyari. Mathematical and Machine Learning Models of Renal Cell Carcinoma: A Review. Bioengineering 2023; 10(11): 1320 doi: 10.3390/bioengineering10111320
|
| 2 |
Jeannette C. Oosterwijk-Wakka, Mirjam C.A. de Weijert, Gerben M. Franssen, Dimitar R. Kolev, Ton A.F.J. de Haan, Otto C. Boerman, Peter F.A. Mulders, Egbert Oosterwijk. Combination of sunitinib and 177Lu-labeled antibody cG250 targeted radioimmunotherapy: A promising new therapeutic strategy for patients with advanced renal cell cancer. Neoplasia 2022; 32: 100826 doi: 10.1016/j.neo.2022.100826
|
| 3 |
Tong Zhang, Ying Ming, Jingxu Xu, Ke Jin, Chencui Huang, Mingguang Duan, Kaiguo Li, Yuanwei Liu, Yonghui Lv, Jie Zhang, Zhaoqin Huang. Radiomics and Ki-67 index predict survival in clear cell renal cell carcinoma. The British Journal of Radiology 2023; 96(1150) doi: 10.1259/bjr.20230187
|
| 4 |
Wengang Jian, Wei Xue, Tengda Wang, Yongchun Yu, Licheng Cai, Yuyang Meng, Zhinan Xia, Cheng Zhang. RBM4 inhibits the growth of clear cell renal cell carcinoma by enhancing the stability of p53 mRNA. Molecular Carcinogenesis 2023; 62(4): 464 doi: 10.1002/mc.23499
|
| 5 |
Ibrahim Elmakaty, Ruba Abdo, Ahmed Elsabagh, Abdelrahman Elsayed, Mohammed Imad Malki. Comparative efficacy and safety of PD-1/PD-L1 inhibitors in triple negative breast cancer: a systematic review and network meta-analysis of randomized controlled trials. Cancer Cell International 2023; 23(1) doi: 10.1186/s12935-023-02941-7
|
| 6 |
Mosunmoluwa Oyenuga, Mohamed M. G. Mohamed, Sara Sartaj, Rushin Patel, Abayomi Oyenuga, Sandeep Sen. Efficacy and safety of Nivolumab in patients with advanced esophageal, gastroesophageal, and gastric cancers: a meta-analysis of randomized controlled trials. Immunopharmacology and Immunotoxicology 2023; 45(1): 10 doi: 10.1080/08923973.2022.2117629
|
| 7 |
Takashi Sawada, Mamoru Narukawa. A Systematic Review of Treatment-Related Adverse Events for Combination Therapy of Multiple Tyrosine Kinase Inhibitor and Immune Checkpoint Inhibitor. Cancer Control 2024; 31 doi: 10.1177/10732748241244586
|
| 8 |
Yongchang Lai, Zhibiao Li, Zechao Lu, Hanxiong Zheng, Chiheng Chen, Can Liu, Yafei Yang, Fucai Tang, Zhaohui He. Roles of DNA damage repair and precise targeted therapy in renal cancer (Review). Oncology Reports 2022; 48(6) doi: 10.3892/or.2022.8428
|
| 9 |
Margaret F. Meagher, Andrea Minervini, Maria C. Mir, Clara Cerrato, Giacomo Rebez, Riccardo Autorino, Lance Hampton, Riccardo Campi, Maximilian Kriegmair, Estefania Linares, Vital Hevia, Maria Musquera, Mauricio D'Anna, Eduard Roussel, Maarten Albersen, Nicola Pavan, Francesco Claps, Alessandro Antonelli, Michele Marchioni, Nail Paksoy, Selcuk Erdem, Ithaar H. Derweesh. Does the Timing of Cytoreductive Nephrectomy Impact Outcomes? Analysis of REMARCC Registry Data for Patients Receiving Tyrosine Kinase Inhibitor Versus Immune Checkpoint Inhibitor Therapy. European Urology Open Science 2024; 63: 71 doi: 10.1016/j.euros.2024.02.001
|
| 10 |
Mark DeBenedette, Alicia Gamble, Marcus Norris, Joe Horvatinovich, Charles A. Nicolette. A review of the clinical experience with CMN-001, a tumor RNA loaded dendritic cell immunotherapy for the treatment of metastatic renal cell carcinoma. Human Vaccines & Immunotherapeutics 2023; 19(2) doi: 10.1080/21645515.2023.2220629
|
| 11 |
Tomislav Pejčić, Zoran Todorović, Siniša Đurašević, Lazar Popović. Mechanisms of Prostate Cancer Cells Survival and Their Therapeutic Targeting. International Journal of Molecular Sciences 2023; 24(3): 2939 doi: 10.3390/ijms24032939
|